JK Pharmachem Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Sep ' 05	Sep ' 04	Sep ' 03	Sep ' 02	Sep ' 01

Sources of funds

Owner's fund

Equity share capital

62.68

62.68

62.68

62.68

62.68

Share application money

-

-

-

-

-

Preference share capital

31.32

31.32

31.32

31.32

31.32

Reserves & surplus

-100.10

-87.62

-50.24

-44.60

-55.44

Loan funds

Secured loans

105.23

99.68

92.01

94.72

99.18

Unsecured loans

5.85

7.04

8.06

8.12

7.65

Total

104.98

113.11

143.84

152.24

145.40

Uses of funds

Fixed assets

Gross block

191.80

192.49

191.66

190.51

189.51

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

85.64

85.65

75.77

66.17

56.44

Net block

106.17

106.84

115.89

124.34

133.07

Capital work-in-progress

-

-

0.03

0.08

1.48

Investments

0.11

0.11

0.11

0.11

0.11

Net current assets

Current assets, loans & advances

6.27

17.16

58.58

38.54

24.82

Less : current liabilities & provisions

7.57

11.35

31.55

12.11

16.66

Total net current assets

-1.30

5.81

27.03

26.43

8.16

Miscellaneous expenses not written

-

0.34

0.77

1.28

2.58

Total

104.98

113.11

143.84

152.24

145.40

Notes:

Book value of unquoted investments

0.11

0.11

0.11

0.11

0.11

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

0.92

20.72

20.55

21.99

21.87

Number of equity sharesoutstanding (Lacs)

626.85

626.85

626.85

626.85

626.85